CoChat

Successful maintenance on sulphonylurea therapy and low diabetes complication rates in a HNF1A–MODY cohort

Bacon, S., Kyithar, M. P., Rizvi, S. R., Donnelly, E., McCarthy, A., Burke, M., Colclough, K., Ellard, S., Byrne, M. M. · 2016 · Diabetic Medicine
Cited by 94

The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.

Abstract

Aims: HNF1A gene mutations are the most common cause of maturity‐onset diabetes of the young (MODY) in the UK. Persons with HNF 1A–MODY display sensitivity to sulphonylurea therapy; however, the long‐term efficacy is not established. There is limited literature as to the prevalence of micro‐ and macrovascular complications in this unique cohort. The aim of this study was to determine the natural progression and clinical management of HNF 1A–MODY diabetes in a dedicated MODY clinic. Methods: Sixty patients with HNF 1A–MODY and a cohort of 60 BMI‐, age‐, ethnicity‐ and diabetes duration‐matched patients with Type 1 diabetes mellitus participated in the study. All patients were phenotyped in detail. Clinical follow‐up of the HNF 1A–MODY cohort occurred on a bi‐annual basis. Results: Following a genetic diagnosis of MODY, the majority of the cohort treated with sulphonylurea therapy remained insulin independent at 84–month follow‐up (80%). The HbA 1c in the HNF 1A–MODY group treated with sulphonylurea therapy alone improved significantly over the study period [from 49 (44–63) mmol/mol, 6.6 (6.2–7.9)% to 41 (31–50) mmol/mol, 5.9 (5–6.7)%; P = 0.003]. The rate of retinopathy was significantly lower than that noted in the Type 1 diabetes mellitus group (13.6 vs. 50%; P = 0.0001).There was also a lower rate of microalbuminuria and cardiovascular disease in the HNF 1A–MODY group compared with the Type 1 diabetes mellitus group. Conclusions: This study demonstrates that the majority of patients with HNF 1A–MODY can be maintained successfully on sulphonylurea therapy with good glycaemic control. We note a significantly lower rate of micro‐ and macrovascular complications than reported previously. The use of appropriate therapy at early stages of the disorder may decrease the incidence of complications.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/dme.12992

Cites

7 of 7 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 94

Metadata

Authors
Bacon, S., Kyithar, M. P., Rizvi, S. R., Donnelly, E., McCarthy, A., Burke, M., Colclough, K., Ellard, S., & Byrne, M. M.
Venue
Diabetic Medicine
Publisher
Wiley
Published
2015-11-17
Volume
33
Issue
7
Pages
976-984
ISSN
  • 0742-3071 (ISSN-L)
  • 1464-5491
OpenAlex
W2113865976
Cited by
94
References
7
FWCI
3.91
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.